Public Health and Disease Control

<h1>Public Health and Disease Control</h1> <p>Singapore's public health system covers population-level prevention, surveillance, and control of infectious and environmental health threats — work that sits alongside, but is distinct from, the hospital-centric clinical system described in <a href="/en/knowledge/article/sgkb.healthcare.healthcare-system-overview">healthcare system overview</a>. Where <a href="/en/knowledge/article/sgkb.healthcare.hospitals">hospitals</a> and <a href="/en/knowledge/article/sgkb.healthcare.polyclinics-and-primary-care">polyclinics and primary care</a> treat individual patients, public health agencies watch whole populations: mandating disease notification, running national vaccination schedules, inspecting food premises, suppressing mosquito vectors, and coordinating outbreak response. Since <strong>April 2025</strong>, the <strong>Communicable Diseases Agency (CDA)</strong> is the dedicated public health authority for communicable diseases under the Ministry of Health (MOH), consolidating infectious-disease functions previously spread across MOH headquarters, the <strong>Health Promotion Board (HPB)</strong>, and the National Centre for Infectious Diseases (NCID) (<a href="https://www.moh.gov.sg/newsroom/formation-of-communicable-diseases-agency-and-appointment-of-professor-vernon-lee-as-ceo/">MOH, Feb 2025</a>; <a href="https://www.cda.gov.sg/about-cda/who-we-are/">CDA, accessed Aug 2026</a>). HPB remains MOH’s statutory board for health promotion and chronic-disease prevention, while the National Environment Agency (NEA) continues as the national authority on environmental public health (<a href="https://www.hpb.gov.sg/about/about-us/">HPB, accessed Aug 2026</a>; <a href="https://www.nea.gov.sg/corporate-functions/who-we-are/groups-and-divisions/public-health-groups-and-divisions">NEA, accessed Aug 2026</a>). Agency-role anchors without invented outbreak tallies are in <a href="/en/knowledge/dataset/sgkb.data.public-health-agency-anchors">public health agency anchors</a>.</p> <h2>The Communicable Diseases Agency</h2> <p>The Communicable Diseases Agency, established in April 2025 as a statutory board under MOH, is Singapore's dedicated public health authority for communicable diseases (<a href="https://www.cda.gov.sg/about-cda/who-we-are/">CDA, accessed Aug 2026</a>). CDA consolidates detection, prevention, and control functions previously distributed across MOH headquarters, HPB, and NCID — a reorganisation announced during the 2023 parliamentary debate on Singapore's COVID-19 response and formally launched by the Prime Minister on 12 November 2025 (<a href="https://www.cda.gov.sg/news-and-events/official-launch-of-communicable-diseases-agency/">CDA launch, Nov 2025</a>). NCID continues as a clinical centre within the CDA structure, with its executive director reporting through the agency (<a href="https://www.cda.gov.sg/about-cda/who-we-are/">CDA, accessed Aug 2026</a>).</p> <p>CDA's mandate spans five operational areas: <strong>prevent</strong> disease spread through vaccination policy, public education, and infection prevention; <strong>prepare</strong> sectoral readiness and access to vaccines and therapeutics; <strong>detect</strong> through strengthened surveillance including new modalities and data analytics; <strong>respond</strong> to cases and outbreaks with investigation, contact tracing, and public health measures; and <strong>enable</strong> these functions through research and international cooperation (<a href="https://www.moh.gov.sg/newsroom/formation-of-communicable-diseases-agency-and-appointment-of-professor-vernon-lee-as-ceo/">MOH, Feb 2025</a>). Early initiatives after becoming operational include the Singapore Pandemic Preparedness and Response Framework in July 2025 and a September 2025 update to the National Adult Immunisation Schedule adding Shingrix and PCV20 (<a href="https://www.cda.gov.sg/news-and-events/official-launch-of-communicable-diseases-agency/">CDA launch, Nov 2025</a>).</p> <p>The split from HPB is structurally important for retrieval. HPB, established in 2001, remains MOH's agency for health promotion and disease prevention — nutrition, physical activity, mental well-being, health screening, tobacco control, and lifestyle programmes that support Healthier SG — but is <strong>not</strong> the lead infectious-disease surveillance and outbreak-control authority after CDA’s formation (<a href="https://www.hpb.gov.sg/about/about-us/">HPB, accessed Aug 2026</a>; <a href="/en/knowledge/dataset/sgkb.data.public-health-agency-anchors">public health agency anchors</a>). CDA owns communicable-disease epidemiology, the national immunisation policy schedules, outbreak investigation, and the National Public Health Laboratory. Clinical treatment of infected patients still flows through hospitals and primary care; CDA sets the population-level rules and coordinates the response around them. This article does not invent current outbreak case counts; for incidence, use the dated CDA surveillance release that matches the question’s period.</p> <h2>Disease surveillance and outbreak response</h2> <p>Singapore's principal legislation for infectious disease control is the <strong>Infectious Diseases Act (IDA)</strong>, jointly administered by MOH, the Singapore Food Agency (SFA), and NEA (<a href="https://www.cda.gov.sg/public/infectious-diseases-act/">CDA, accessed Aug 2026</a>). The IDA empowers the Director-General of Health to require notification of listed infectious diseases, isolate and treat infected persons, conduct contact tracing and quarantine, and order disinfection of premises. It provides a tiered hierarchy of responses — including declaration of a Public Health Threat or Public Health Emergency by the Minister for Health — so outbreak management can scale with severity. Port-of-entry measures to prevent disease importation are also stipulated under the Act.</p> <p><strong>Notifiable disease surveillance</strong> is the backbone of detection. Licensed doctors and laboratories must report specified infectious diseases to the authorities; CDA publishes annual surveillance reports covering air/droplet-borne, vector-borne, food-borne, blood-borne, and sexually transmitted diseases, alongside programme coverage data (<a href="https://www.cda.gov.sg/resources/communicable-diseases-surveillance-singapore-2023-2024/">CDA surveillance report 2023–2024, Dec 2025</a>). Clinical case reporting is supplemented by environmental and laboratory modalities. NEA's Environmental Health Institute (EHI) runs arbovirus diagnostics, genomic surveillance of dengue virus serotypes, and a wastewater surveillance network covering more than 500 sampling sites — initiated in February 2020 for SARS-CoV-2 and expanded from mid-2023 to include Zika virus, in partnership with CDA and PUB (<a href="https://www.nea.gov.sg/corporate-functions/resources/research/environmental_health_institute/wastewater-surveillance-programme/">NEA wastewater programme, accessed Aug 2026</a>). Wastewater sampling can capture community-level transmission including from mildly symptomatic or asymptomatic individuals who may not seek care, complementing clinical surveillance.</p> <p>When an outbreak is detected, CDA investigates cases, traces contacts, and recommends or implements control measures — the same operational chain exercised at scale during COVID-19 and in smaller episodes such as dengue clusters and food-borne incidents. NEA contributes vector-control operations and environmental disinfection during outbreaks; SFA handles food-safety enforcement where contaminated food is implicated. The IDA's tiered framework allows graduated measures — from targeted quarantine to economy-wide safe-management rules — without requiring ad hoc legislation for each crisis.</p> <h2>Mask rules and respiratory-infection precautions</h2> <p>Singapore has no blanket COVID-19 mask requirement for people in ordinary public places or on public transport: the temporary COVID-19 legal requirement was stepped down on <strong>13 February 2023</strong>. From <strong>1 March 2024</strong>, MOH also ended compulsory mask-wearing in lower-risk outpatient settings, including polyclinics, GP and specialist outpatient clinics, dialysis centres, TCM clinics and dental clinics. MOH says masks remain required in higher-risk healthcare settings — inpatient wards, emergency departments and residential-care facilities — to protect medically vulnerable people and older residents; hospital inpatients and care-home residents themselves are not required to wear one. In outpatient settings, MOH strongly encourages masking for medically vulnerable people, seniors and people with acute respiratory infection symptoms (<a href="https://www.moh.gov.sg/newsroom/integrating-our-covid-19-response-protocols-into-our-broader-public-health-programmes/">MOH, 29 Feb 2024</a>).</p> <p>These are not the only possible rules: another regulator or a private organisation can set a mask requirement for its own premises or workforce. Separately, CDA's <strong>21 May 2026</strong> public advisory recommends wearing a mask when experiencing symptoms such as a runny nose, sore throat, headache or fever; this is infection-control advice, not a general public-place legal mandate. MOH also advises symptomatic people who need to go out to mask up, avoid crowded places and avoid contact with vulnerable people (<a href="https://www.cda.gov.sg/news-and-events/cda-statement--update-on-covid-19-situation-in-singapore/">CDA, 21 May 2026</a>; <a href="https://www.moh.gov.sg/newsroom/singapore-to-exit-acute-phase-of-pandemic/">MOH, 13 Feb 2023</a>). For a current facility-specific requirement, follow that facility's notice and the latest MOH/CDA direction; the 2020–2022 pandemic rules should not be read as today's general rule.</p> <h2>Mask and respirator types: what the filtration figures mean</h2> <p>HSA distinguishes loose-fitting cloth or paper face masks, surgical masks, N95 respirators and surgical N95 respirators by intended use, fit and test. A cloth or paper face mask mainly provides source control by reducing large particles expelled by the wearer. A surgical mask is a medical device, also supports source control and can act as a barrier against larger droplets or splashes, but it does not seal tightly to the face. HSA reports bacterial filtration efficiency above 95% for surgical masks under the relevant medical-mask standard. An N95 respirator instead forms a tight seal when correctly fitted and is certified to filter at least 95% of specified non-oil particulate aerosols around 0.3 microns; it is not tested for resistance to bodily-fluid splashes. A surgical N95 combines the respirator's particle protection with fluid resistance (<a href="https://www.hsa.gov.sg/announcements/guide-to-masks-and-respirators/">HSA, Guide to Masks and Respirators, 28 May 2026</a>; <a href="https://www.hsa.gov.sg/announcements/what-you-need-to-know-about-masks/">HSA, What You Need to Know About Masks, 28 May 2026</a>).</p> <p>The percentages are results from different test methods and do <strong>not</strong> mean that a surgical mask and an N95 provide the same kind of 95% protection, or that either guarantees a wearer's real-world protection against every virus. Gaps around the face can let air bypass a filter; HSA says respirators require appropriate fit testing and a seal check. For haze particles, NEA likewise says N95-equivalent protection depends on a suitable, leak-free fit and is generally unnecessary for short outdoor commutes or indoor settings; its guidance is not a recommendation to wear N95 routinely for ordinary daily activity. People with breathing difficulty or relevant heart or lung conditions should follow NEA's current advice and consult a clinician where indicated (<a href="https://www.hsa.gov.sg/announcements/guide-to-masks-and-respirators/">HSA, Guide to Masks and Respirators, 28 May 2026</a>; <a href="https://www.nea.gov.sg/our-services/pollution-control/air-pollution/faqs">NEA, Haze FAQs, accessed 8 Nov 2026</a>).</p> <h2>National immunisation programmes</h2> <p>Singapore maintains two nationally recommended vaccination schedules reviewed by MOH in consultation with the Expert Committee on Immunisation (ECI): the <strong>National Childhood Immunisation Schedule (NCIS)</strong> and the <strong>National Adult Immunisation Schedule (NAIS)</strong>, published by CDA (<a href="https://www.cda.gov.sg/public/vaccinations/">CDA vaccinations, May 2026</a>). The NCIS covers 14 vaccine-preventable diseases — tuberculosis, hepatitis B, diphtheria, tetanus, pertussis, poliovirus, Haemophilus influenzae type b, measles, mumps, rubella, varicella, pneumococcal disease, human papillomavirus, and influenza — with age-specific dosing from birth through adolescence. Vaccinations against <strong>measles and diphtheria are compulsory</strong> for children under the IDA; that legal obligation is distinct from the broader set of vaccines recommended in the NCIS (<a href="https://www.cda.gov.sg/public/vaccinations/">CDA vaccinations, May 2026</a>; <a href="https://www.nir.cda.gov.sg/eservices/parentalfaq">CDA NIR FAQ, accessed Nov 2026</a>). The NAIS, established in November 2017, recommends vaccines for adults aged 18 and above against 12 diseases, with schedules tailored by age, occupation, medical conditions, and vaccination history (<a href="https://www.cda.gov.sg/public/vaccinations/">CDA vaccinations, May 2026</a>).</p> <p>Vaccines are delivered through multiple channels. Childhood doses are given at birth in hospitals, at <a href="/en/knowledge/article/sgkb.healthcare.polyclinics-and-primary-care">polyclinics</a> and private paediatric clinics, and through a <strong>school-based programme</strong> in which Tdap, IPV, HPV (for females), and MMR catch-up vaccines are provided at Primary 5, Secondary 1, and Secondary 2 (<a href="https://www.cda.gov.sg/public/vaccinations/">CDA vaccinations, May 2026</a>). Adult and senior vaccinations are available at participating CHAS clinics and public healthcare institutions; nationally recommended vaccines under the NAIS and NCIS receive subsidies at public healthcare settings, and Healthier SG enrollees can access fully subsidised NAIS vaccines at their enrolled clinic (<a href="https://www.cda.gov.sg/public/vaccinations/">CDA vaccinations, May 2026</a>; see <a href="/en/knowledge/article/sgkb.healthcare.healthcare-financing">healthcare financing</a> for the wider subsidy framework). The <strong>National Immunisation Registry</strong> records vaccination history, accessible to residents through an online portal and used to verify immunisation status for foreign-born children applying for long-term immigration passes (<a href="https://www.cda.gov.sg/public/vaccinations/">CDA vaccinations, May 2026</a>). HPB continues to run public-education campaigns promoting adult immunisation — for example urging seniors to take subsidised pneumococcal vaccines under Healthier SG — but policy and schedule ownership sit with CDA.</p> <p>For a dose given overseas that is missing from the NIR, submit a vaccination-record update through the NIR portal; CDA says, from <strong>12 May 2025</strong>, new additions or amendments are accepted through that portal. Include clear supporting records, and provide both the original and an English translation for documents not in English. CDA's FAQ gives an indicative processing time of about <strong>10 working days</strong> when documents are complete and legible, excluding weekends and public holidays; school-registration periods can take longer. A separate NIR service verifies vaccination records for a <strong>foreign-born child applying for a long-term stay in Singapore</strong>. This verification route is not the same as updating an existing record, and neither process by itself establishes that every overseas vaccine product is registered for local supply or tells a clinician which dose is next (<a href="https://www.nir.cda.gov.sg/eservices/parentalfaq">CDA NIR Parent FAQ, accessed Nov 2026</a>; <a href="https://www.cda.gov.sg/about-cda/contact-us/">CDA Contact, accessed Nov 2026</a>). For a child's clinical catch-up plan, consult a doctor; the schedule and the child's documentary record answer different questions.</p> <h2>Current COVID-19 vaccination guidance and record boundaries</h2> <p>From <strong>12 October 2026</strong>, COVID-19 vaccination was incorporated into both the National Childhood Immunisation Schedule (NCIS) and National Adult Immunisation Schedule (NAIS). MOH recommends it for people aged 60 and above, medically vulnerable people aged 6 months and above, and residents of aged-care facilities; healthcare workers and people living or working with medically vulnerable people are encouraged to receive it. Others aged six months and above who want vaccination may also receive it. This is a clinical recommendation, not a universal legal mandate (<a href="https://www.moh.gov.sg/newsroom/covid-19-vaccination-to-be-incorporated-into-national-immunisation-schedules/">MOH, 7 October 2026</a>).</p> <p>For a first COVID-19 vaccination, an unvaccinated child aged 6 months to 4 years is recommended two doses eight weeks apart; an unvaccinated person aged 5 years or older is recommended one dose. People aged six months and above who were vaccinated previously are recommended an additional dose around one year after their last dose, and not earlier than five months. Updated XFG Moderna/Spikevax was rolled out from 12 October 2026 for ages 6 months and above; updated XFG Pfizer-BioNTech/Comirnaty was available from that date for ages 12 and above, and from 2 November 2026 for ages 6 months to 11 years. Availability at a particular clinic should be checked before visiting (<a href="https://www.moh.gov.sg/newsroom/covid-19-vaccination-to-be-incorporated-into-national-immunisation-schedules/">MOH, 7 October 2026</a>).</p> <p>As of MOH's 7 October 2026 notice, COVID-19 vaccination remained fully subsidised, until further review, for Singapore citizens, permanent residents, Long-Term Pass holders and certain Short-Term Pass holders at participating CHAS GP clinics, polyclinics and Mobile Vaccination Team sites. The same notice says COVID-19 vaccination is not claimable under MediSave 500/700 or the MediSave Chronic and Preventive Care scheme from 1 January 2027, until further review. This is not a claim that every vaccine is free to every person at every provider; check the participating site's eligibility and availability before attending (<a href="https://www.moh.gov.sg/newsroom/covid-19-vaccination-to-be-incorporated-into-national-immunisation-schedules/">MOH, updated 6 November 2026</a>).</p> <p>For overseas COVID-19 vaccinations, MOH allows clinics to enter records into the National Immunisation Registry (NIR) with acceptable documentary proof <strong>without serology testing or a digital certificate</strong>. This is a record-ingestion rule; it does not itself say that every foreign product is approved for use in Singapore or decide what dose a person should receive next. Since 1 March 2024, COVID-19 vaccination has also ceased to be a requirement for Permanent Residence, Long-Term Pass or Work Pass applications and renewals; vaccination remains encouraged (<a href="https://isomer-user-content.by.gov.sg/7/a5246b7a-6467-4680-827a-2217c3b57c4c/moh-cir-13-2024-integrating-our-covid-19-response-protocols-into-public-health-programmes.pdf">MOH Circular 13/2024</a>; <a href="https://www.mom.gov.sg/covid-19-vaccination-requirements-for-mom-passes">MOM, accessed 7 November 2026</a>).</p> <h2>NEA and environmental public health</h2> <p>The National Environment Agency is Singapore's national authority on <strong>environmental public health</strong> — the non-clinical layer of public health that keeps the physical environment from becoming a disease vector or contamination source (<a href="https://www.nea.gov.sg/corporate-functions/who-we-are/groups-and-divisions/public-health-groups-and-divisions">NEA, accessed Aug 2026</a>). NEA's public health pillar spans vector control, sanitation, food-hygiene enforcement, public cleanliness, port health, and after-death services. This is distinct from MOH/CDA's clinical epidemiology mandate but tightly coupled to it: mosquito abundance drives dengue risk, and food-hygiene lapses drive food-borne outbreaks.</p> <p><strong>Food hygiene</strong> is a major NEA operational area. NEA licenses retail food establishments, inspects premises against the Code of Practice on Environmental Health (COPEH), and operates a Points Demerit System that can suspend licences after repeated lapses (<a href="https://www.nea.gov.sg/corporate-functions/who-we-are/groups-and-divisions/public-health-groups-and-divisions">NEA, accessed Aug 2026</a>). The <strong>Food Hygiene Recognition Scheme</strong> awards Bronze, Silver, or Gold decals to operators with consistent inspection track records of at least two, five, or ten years without major lapses — replacing the older annual A/B/C/D snapshot grading to reward sustained compliance (<a href="https://www.nea.gov.sg/media/readers-letters/index/new-grading-system-takes-into-account-the-track-record-of-eateries-from-every-hygiene-inspection">NEA, accessed Aug 2026</a>). Consumers can check suspension history and demerit points on NEA's Food Hygiene Information Portal. Food stall licences at hawker centres are issued by SFA, with NEA managing tenancy and environmental standards at NEA-managed <a href="/en/knowledge/article/sgkb.food-hawker-culture.hawker-centres">hawker centres</a> (<a href="https://www.nea.gov.sg/our-services/hawker-management/becoming-a-hawker">NEA hawker licensing, accessed Aug 2026</a>). SFA regulates food safety across the supply chain from import through manufacturing and distribution; NEA focuses on hygienic preparation and premises standards at the retail and food-service level.</p> <p><strong>Vector control</strong> is NEA's other high-profile public health function. The Environmental Public Health Operations Group deploys regional offices for ground operations — inspections, enforcement, and outbreak intervention — while the Environmental Health Institute researches vector biology, runs Project Wolbachia (mass release of Wolbachia-infected male <em>Aedes aegypti</em> mosquitoes to suppress wild populations and reduce dengue transmission), and integrates case, vector, virus, and ecological surveillance into outbreak forecasting (<a href="https://www.nea.gov.sg/corporate-functions/who-we-are/groups-and-divisions/public-health-groups-and-divisions">NEA EHI, accessed Aug 2026</a>). NEA also oversees public cleanliness, environmental sanitation during infectious-disease outbreaks, and the Haze Task Force that coordinates inter-agency air-quality responses during transboundary haze episodes (see <a href="/en/knowledge/article/sgkb.environment-sustainability.haze">haze</a>).</p> <h2>One Health coordination across agencies</h2> <p>Singapore adopted a <strong>One Health</strong> approach in 2012, recognising that human, animal, and environmental health are linked — zoonotic diseases, food safety, antimicrobial resistance, and vector ecology do not respect agency boundaries (<a href="https://www.cda.gov.sg/public/one-health/singapore-one-health-master-plan/">CDA One Health, Dec 2025</a>). The <strong>Singapore One Health Master Plan</strong>, published in December 2025, sets the national strategy across three pillars: engagements (communications, networking, leadership), sector development (partnerships and education), and insights (research, information sharing, and surveillance). CDA, NEA, NParks, PUB, and SFA collaborated on the plan through workshops in 2024 and 2025 (<a href="https://www.cda.gov.sg/public/one-health/singapore-one-health-master-plan/">CDA One Health, Dec 2025</a>).</p> <p>The framework's practical effects are everyday: integrated food safety from farm to hawker table; coordinated response when residents report sick wildlife; wastewater pathogen monitoring alongside clinical case counts; and joint rat-control enforcement with SFA at premises with poor refuse management (<a href="https://www.cda.gov.sg/public/one-health/singapore-one-health-master-plan/">CDA One Health, Dec 2025</a>; <a href="https://www.nea.gov.sg/corporate-functions/who-we-are/groups-and-divisions/public-health-groups-and-divisions">NEA, accessed Aug 2026</a>). ONEHealthSG branding unifies the inter-agency initiative. For residents, the distinction between agencies matters less than the outcome: clinical care when sick through <a href="/en/knowledge/article/sgkb.healthcare.polyclinics-and-primary-care">polyclinics and primary care</a> and <a href="/en/knowledge/article/sgkb.healthcare.hospitals">hospitals</a>, prevention through vaccination schedules and Healthier SG screenings, and environmental protection through NEA's inspection and vector-control regimes — all layers of a single public health defence.</p>

简介

公共卫生与疾病控制

新加坡的公共卫生体系涵盖人口层面的预防、监测以及对传染病和环境健康威胁的控制;这些工作与以医院为中心的临床体系并行,但彼此有别,后者见医疗体系概览。医院以及综合诊疗所与基层医疗为个别患者提供治疗,公共卫生机构则关注整个人群:强制疾病通报、开展国家疫苗接种计划、检查食品经营场所、控制蚊媒,以及协调疫情应对。自2025 年四月起,**传染病局(CDA)**成为卫生部(MOH)下属专责传染病公共卫生机构,整合了此前分散在卫生部总部、**健康促进局(HPB)**和国家传染病中心(NCID)的传染病职能(卫生部,2025 年二月;CDA,查阅于 2026 年八月)。HPB仍是卫生部负责健康促进和慢性病预防的法定机构,而国家环境局(NEA)继续担任国家环境公共卫生主管机构(HPB,查阅于 2026 年八月;NEA,查阅于 2026 年八月)。有关各机构职责的依据见公共卫生机构依据,其中没有编造疫情统计数字。

传染病局

传染病局于 2025 年四月成立,是卫生部下属的法定机构,也是新加坡专责传染病的公共卫生主管机构(CDA,查阅于 2026 年八月)。CDA整合了此前分散在卫生部总部、HPB和NCID的传染病侦测、预防和控制职能。这项重组在 2023 年国会辩论新加坡应对COVID-19 疫情的过程中公布,并于 2025 年十一月 12 日由总理正式主持成立仪式(CDA成立仪式,2025 年十一月)。NCID继续作为CDA架构内的临床中心运作,其执行主任向该局汇报(CDA,查阅于 2026 年八月)。

CDA的职责涵盖五个工作领域:通过疫苗接种政策、公众教育和感染预防来预防疾病传播;做好各领域准备,并确保疫苗和治疗药物的供应;通过强化监测,包括采用新方法和数据分析来侦测疾病;通过调查、接触者追踪和公共卫生措施来应对病例和疫情;并通过研究和国际合作来支持这些工作(卫生部,2025 年二月)。开始运作后的早期举措包括 2025 年七月推出的新加坡疫情防备与应对框架,以及 2025 年九月更新国家成人免疫接种计划,加入Shingrix和PCV20(CDA成立仪式,2025 年十一月)。

HPB与CDA的职能划分在资料检索方面具有重要的结构性意义。HPB成立于 2001 年,仍是卫生部负责健康促进和疾病预防的机构,工作涵盖营养、体育活动、心理健康、健康筛查、烟草控制,以及支持“健康SG”的生活方式计划;但在CDA成立后,HPB不再是传染病监测和疫情控制的主责机构(HPB,查阅于 2026 年八月;公共卫生机构依据)。CDA负责传染病流行病学、国家免疫接种政策计划、疫情调查以及国家公共卫生实验室。感染者的临床治疗仍由医院和基层医疗机构负责;CDA制定人口层面的规则并协调相关应对工作。本文不编造当前疫情病例数;如需了解发病情况,应使用与问题所涉时期相符、注明日期的CDA监测资料。

疾病监测与疫情应对

新加坡用于控制传染病的主要法律是《传染病法令(IDA)》,由卫生部、新加坡食品局(SFA)和NEA共同管理(CDA,查阅于 2026 年八月)。IDA授权卫生总监要求通报列明的传染病、隔离和治疗感染者、开展接触者追踪和隔离,以及下令消毒场所。该法令设有分级应对机制,包括卫生部长宣布出现公共卫生威胁或公共卫生紧急情况,使疫情管理措施可根据严重程度逐步升级。法令也规定了预防疾病经入境口岸传入的措施。

法定通报疾病监测是疾病侦测的基础。持牌医生和实验室必须向有关当局报告指定传染病;CDA发布年度监测报告,涵盖经空气或飞沫传播、经病媒传播、经食物传播、经血液传播和性传播的疾病,并附有各项计划的覆盖率数据(CDA《2023–2024 年新加坡传染病监测报告》,2025 年十二月)。临床病例报告还辅以环境监测和实验室监测。NEA环境卫生研究所(EHI)开展虫媒病毒诊断、登革热病毒血清型基因组监测,并运营一个覆盖 500 多个采样点的污水监测网络。该网络于 2020 年二月启动,用于监测SARS-CoV-2;自 2023 年年中起扩大监测范围,将寨卡病毒纳入其中,并与CDA和PUB合作(NEA污水监测计划,查阅于 2026 年八月)。污水采样能捕捉社区层面的传播情况,包括症状轻微或无症状、可能不会求医的人群传播,从而补充临床监测。

发现疫情后,CDA会调查病例、追踪接触者,并建议或落实管控措施;COVID-19 疫情期间大规模采用了这套工作流程,登革热感染群和食源性事件等较小规模的疫情也沿用相同机制。疫情期间,NEA负责病媒控制行动和环境消毒;若涉及受污染食物,则由SFA负责食品安全执法。IDA的分级框架使措施可逐步升级,从针对性隔离到适用于全经济体系的安全管理规定,无须每次危机都临时立法。

口罩规定与呼吸道感染防护建议

在普通公共场所或公共交通工具上,新加坡没有全面的COVID-19 口罩佩戴规定:临时COVID-19 法定要求已于2023 年二月 13 日取消。自2024 年三月 1 日起,卫生部也取消了较低风险门诊场所的强制戴口罩规定,包括综合诊疗所、全科医生和专科门诊、透析中心、中医诊所以及牙科诊所。卫生部表示,较高风险的医疗场所仍须戴口罩,包括住院病房、急诊部门和住院护理设施,以保护医学上较脆弱的人士和年长住户;医院住院病人和护理院住户本人则无须戴口罩。在门诊场所,卫生部强烈建议医学上较脆弱的人士、年长者以及有急性呼吸道感染症状的人戴口罩(卫生部,2024 年二月 29 日)。

其他规定仍有可能适用:其他监管机构或私人组织可为其场所或员工制定口罩要求。此外,CDA于2026 年五月 21 日发布的公众建议,建议出现流鼻涕、喉咙痛、头痛或发烧等症状时戴口罩;这是感染控制建议,并非公共场所的一般法定规定。卫生部也建议有症状的人如须外出,应戴好口罩、避开拥挤场所,并避免接触易受感染的人士(CDA,2026 年五月 21 日;卫生部,2023 年二月 13 日)。如需了解某个设施目前适用的具体规定,应遵循该设施的通知以及卫生部和CDA的最新指示;不应把 2020–2022 年的疫情规定视为当前的一般规则。

口罩和呼吸器类型:过滤率数字的含义

卫生科学局(HSA)根据预期用途、贴合度和测试方法,对宽松佩戴的布口罩或纸口罩、外科口罩、N95呼吸器及外科N95呼吸器作出区分。布口罩或纸口罩主要用于控制传染源,减少佩戴者排出的较大颗粒。外科口罩是医疗器械,也可用于控制传染源,并能阻挡较大的飞沫或液体喷溅,但无法紧密贴合脸部。HSA指出,外科口罩按照相关医用口罩标准测试时,细菌过滤效率超过 95%。N95呼吸器则在正确佩戴时会紧密贴合脸部,并经认证可过滤至少 95% 的特定非油性、约 0.3 微米的颗粒气溶胶;它不经过体液喷溅防护测试。外科N95兼有呼吸器的颗粒防护能力和抗液体喷溅能力(HSA《口罩和呼吸器指南》,2026 年五月 28 日;HSA《关于口罩须知》,2026 年五月 28 日)。

这些百分比来自不同的测试方法,并不表示外科口罩和N95提供同一种 95% 防护,也不表示任何一种口罩都能保证佩戴者在现实环境中免受所有病毒侵害。脸部周围的缝隙可能让空气绕过过滤层;HSA指出,呼吸器需要经过适当的贴合度测试并进行密封检查。对于烟霾颗粒,NEA同样指出,N95级别的防护取决于是否合适且没有漏气的贴合效果;一般而言,短时间户外通勤或在室内时无须佩戴。NEA的指引并不建议日常活动时常规佩戴N95。有呼吸困难或相关心脏、肺部疾病的人士,应遵循NEA的最新建议,并在需要时咨询临床医生(HSA《口罩和呼吸器指南》,2026 年五月 28 日;NEA《烟霾常见问题》,查阅于 2026 年十一月 八日)。

国家免疫接种计划

新加坡维持两项由卫生部与免疫接种专家委员会(ECI)协商并定期审查的国家建议疫苗接种计划:国家儿童免疫接种计划(NCIS)和国家成人免疫接种计划(NAIS),由CDA发布(CDA疫苗接种资料,2026 年五月)。NCIS涵盖 14 种可通过疫苗预防的疾病——结核病、乙型肝炎、白喉、破伤风、百日咳、脊髓灰质炎、b型流感嗜血杆菌感染、麻疹、腮腺炎、风疹、水痘、肺炎球菌疾病、人乳头瘤病毒感染和流感——并按年龄安排从出生至青少年时期的接种剂量。根据IDA规定,儿童必须接种麻疹和白喉疫苗;这项法律义务与NCIS中建议接种的其他疫苗有所区别(CDA疫苗接种资料,2026 年五月;CDA国家免疫登记处常见问题,查阅于 2026 年十一月)。NAIS于 2017 年十一月设立,建议 18 岁及以上成人接种预防 12 种疾病的疫苗,并根据年龄、职业、健康状况和接种史制定不同的接种计划(CDA疫苗接种资料,2026 年五月)。

疫苗通过多个渠道接种。儿童疫苗可在出生时于医院接种,也可在综合诊疗所和私人儿科诊所接种;此外还有学校接种计划,在小五、中学 1 年级和中学 2 年级为学生接种Tdap、IPV、HPV(女性)和补种MMR疫苗(CDA疫苗接种资料,2026 年五月)。成人和年长者可在参与计划的CHAS诊所和公共医疗机构接种疫苗;在公共医疗机构,NAIS和NCIS建议的国家疫苗可获补贴,加入“健康SG”的人则可在所属诊所免费接种NAIS疫苗(CDA疫苗接种资料,2026 年五月;更广泛的补贴制度见医疗保健融资)。国家免疫登记处记录疫苗接种史,居民可通过线上门户查询;该登记处也用于核实申请长期移民准证的外籍出生儿童的免疫接种状况(CDA疫苗接种资料,2026 年五月)。HPB继续开展公众教育活动,推广成人免疫接种,例如鼓励年长者在“健康SG”计划下接种获补贴的肺炎球菌疫苗;但政策和接种计划仍由CDA负责。

如在海外接种的疫苗没有显示在国家免疫登记处(NIR)中,可通过NIR门户提交疫苗接种记录更新申请;CDA表示,自2025 年五月 12 日起,新增或修改记录须通过该门户提交。申请时应附上清晰的证明文件;如文件不是英文,须同时提交原文和英文译文。CDA常见问题说明,如文件齐全且清晰,预计处理时间约为10 个工作日,周末和公共假期不计;学校注册期间可能需要更长时间。另有一项NIR服务,用于核实申请在新加坡长期居留的外籍出生儿童的疫苗接种记录。此核实程序不同于更新现有记录;这两项程序本身都不能证明所有海外疫苗产品均已获准在本地供应,也不能告知临床医生下一剂应接种什么疫苗(CDA国家免疫登记处家长常见问题,查阅于 2026 年十一月;CDA联系资料,查阅于 2026 年十一月)。如需为孩子制定临床补种计划,请咨询医生;接种计划和孩子的文件记录回答的是不同问题。

COVID-19 疫苗接种最新指引与记录范围

自2026 年十月 12 日起,COVID-19 疫苗接种纳入国家儿童免疫接种计划(NCIS)和国家成人免疫接种计划(NAIS)。卫生部建议 60 岁及以上人士、六个月及以上且医学上较脆弱的人士,以及疗养院住户接种疫苗;卫生保健工作者,以及与医学上较脆弱人士同住或一起工作的人士,也建议接种。其他 六个月及以上、希望接种疫苗的人士也可接种。这是临床建议,并非普遍适用的法律强制要求(卫生部,2026 年十月 7 日)。

对于首次接种COVID-19 疫苗,建议未接种疫苗的 6 个月至 4 岁儿童接种两剂,间隔 8 周;建议 5 岁及以上的未接种者接种一剂。建议 6 个月及以上、曾接种疫苗的人士在上一剂后约一年接种加强剂,且不得早于上一剂后 5 个月。更新版XFG Moderna/Spikevax自 2026 年十月 12 日起为 6 个月及以上人士推出;更新版XFG Pfizer-BioNTech/Comirnaty自该日起供 12 岁及以上人士接种,自 2026 年十一月 2 日起供 6 个月至 11 岁儿童接种。前往诊所前,应先确认该诊所是否有疫苗供应(卫生部,2026 年十月 7 日)。

根据卫生部 2026 年十月 7 日的通知,截至该日,参与计划的CHAS全科诊所、综合诊疗所和流动疫苗接种队为新加坡公民、永久居民、长期准证持有者及部分短期准证持有者提供全额补贴的COVID-19 疫苗接种服务,直至另行检讨。该通知指出,自 2027 年一月 1 日起,COVID-19 疫苗接种不可通过MediSave 500/700 或MediSave慢性病与预防保健计划报销,直至另行检讨。这并不表示所有疫苗都对所有人士免费,或每家服务机构都提供疫苗;前往接种前,应确认参与地点的资格要求和疫苗供应情况(卫生部,更新于 2026 年十一月 6 日)。

对于在海外接种的COVID-19 疫苗,卫生部允许诊所在有可接受的文件证明时,将接种记录录入国家免疫登记处(NIR),无须进行血清学检测或提供数码证书。这项规则只规定如何录入记录;它本身并不表示所有海外疫苗产品都获准在新加坡使用,也不决定某人下一剂应接种什么疫苗。自 2024 年三月 1 日起,COVID-19 疫苗接种也不再是申请或续签永久居民、长期准证或工作准证的条件;卫生部仍鼓励接种(卫生部 2024 年第 13 号通告;人力部,查阅于 2026 年十一月 7 日)。

NEA与环境公共卫生

国家环境局是新加坡环境公共卫生主管机构,负责非临床公共卫生工作,确保实体环境不会成为疾病传播媒介或污染源(NEA,查阅于 2026 年八月)。NEA的公共卫生工作涵盖病媒控制、卫生管理、食品卫生执法、公共清洁、港口卫生和身后事务服务。这与卫生部和CDA负责的临床流行病学工作有所区别,但两者密切相关:蚊虫数量会影响登革热风险,食品卫生疏失则会引发食源性疫情。

食品卫生是NEA的重要工作领域。NEA为零售食品经营场所颁发执照,依据《环境卫生操作守则》(COPEH)检查经营场所,并实施扣分制;屡次违规的场所可能被暂停营业执照(NEA,查阅于 2026 年八月)。食品卫生认可计划向持续保持良好检查记录、分别至少两年、五年或十年没有重大违规的经营者颁发铜级、银级或金级贴纸,取代旧有的年度A/B/C/D分级快照评级,以表彰长期合规(NEA,查阅于 2026 年八月)。消费者可通过NEA食品卫生信息门户查看停业记录和扣分情况。小贩中心摊位执照由SFA签发;在NEA管理的小贩中心,NEA负责租赁事务和环境标准(NEA小贩摊位执照资料,查阅于 2026 年八月)。SFA监管从进口到生产和分销的整个供应链食品安全;NEA则着重监管零售和餐饮服务场所的卫生备餐和场所标准。

病媒控制是NEA另一项备受关注的公共卫生职能。环境公共卫生行动组设有区域办事处,负责实地行动,包括检查、执法和疫情干预;环境卫生研究所则研究病媒生物学、开展沃尔巴克氏菌计划(大规模释放感染沃尔巴克氏菌的雄性埃及伊蚊,以抑制野生蚊群并减少登革热传播),并整合病例、病媒、病毒和生态监测资料,用于疫情预测(NEA环境卫生研究所,查阅于 2026 年八月)。NEA也负责公共清洁、传染病疫情期间的环境消毒,以及在跨境烟霾期间协调跨部门空气质量应对措施的烟霾工作小组(见烟霾)。

跨机构的“同一健康”协调

新加坡于 2012 年采用**“同一健康”(One Health)**理念,承认人类、动物和环境健康相互关联;人畜共患病、食品安全、抗微生物药物耐药性和病媒生态都不受机构边界限制(CDA“同一健康”资料,2025 年十二月)。《新加坡“同一健康”总体计划》于 2025 年十二月发布,制定涵盖三个支柱的国家战略:交流(沟通、建立网络、领导力)、领域发展(伙伴关系和教育),以及洞见(研究、信息共享和监测)。CDA、NEA、NParks、PUB和SFA在 2024 年和 2025 年通过研讨会共同制定了该计划(CDA“同一健康”资料,2025 年十二月)。

该框架在日常生活中发挥实际作用,包括从农场到小贩餐桌的综合食品安全;居民报告野生动物患病时的协调应对;在临床病例数之外监测污水病原体;以及SFA与NEA联合执法,处理废弃物管理不善场所的鼠患问题(CDA“同一健康”资料,2025 年十二月;NEA,查阅于 2026 年八月)。ONEHealthSG品牌统一了这项跨机构计划。对居民而言,各机构之间的职责区别不如最终成果重要:生病时通过综合诊疗所与基层医疗和医院获得临床护理,通过疫苗接种计划和“健康SG”筛查进行预防,并依靠NEA的检查和病媒控制制度维护环境卫生——这些都是同一套公共卫生防线的组成部分。